Todd Brown, vice chair of the Department of Pharmacy Practice in the Bouvé College of Health Sciences, analyzes the impact of pending changes to regulations governing access to emergency contraceptives.
3Qs: Are cigarette warning labels effective?
This summer, the U.S. Food and Drug Administration unveiled graphic new cigarette warning labels that will be required to appear on packages starting next year. We talked to law professor Richard Daynard, the president of the School of Law’s Public Health Advocacy Institute and chair of its Tobacco Products Liability Project, about the effectiveness of warning labels and a lawsuit challenging the new labels’ legality.
3Qs: From drug development to treating disease
Mansoor Amiji, distinguished professor and chair of pharmaceutical sciences, tracks the drug discovery process, and analyzes how the pursuit of ‘blockbuster’ drugs compares to treating patients with rare illnesses
